Montes de Oca R - Search Results

1

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Prevots DR, et al. Among authors: montes de oca r. Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6. doi: 10.1164/rccm.201002-0310OC. Epub 2010 Jun 10. Am J Respir Crit Care Med. 2010. PMID: 20538958 Free PMC article.

2

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Seitz AE, et al. Among authors: montes de oca r. Chest. 2010 Oct;138(4):944-9. doi: 10.1378/chest.10-0099. Epub 2010 Apr 30. Chest. 2010. PMID: 20435655 Free PMC article.

3

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE. Page KR, et al. Among authors: montes de oca r. Arch Intern Med. 2006 Sep 25;166(17):1863-70. doi: 10.1001/archinte.166.17.1863. Arch Intern Med. 2006. PMID: 17000943

4

Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014).

Chang CM, Thakur S, Montes de Oca R, Rostron BL, Cheng YC, Wright MJ Jr, van Bemmel DM, Wang L, Hatsukami DK. Chang CM, et al. Among authors: montes de oca r. Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):1083-1090. doi: 10.1158/1055-9965.EPI-23-1471. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38861317

5

T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.

Verkleij CPM, O'Neill CA, Broekmans MEC, Frerichs KA, Bruins WSC, Duetz C, Kruyswijk S, Baglio SR, Skerget S, Montes de Oca R, Zweegman S, Verona RI, Mutis T, van de Donk NWCJ. Verkleij CPM, et al. Among authors: montes de oca r. Clin Cancer Res. 2024 Jul 15;30(14):3006-3022. doi: 10.1158/1078-0432.CCR-23-3333. Clin Cancer Res. 2024. PMID: 38687588

6

Ultrasound-Guided, Mid-Forearm Median Nerve Block for Relief of Carpal Tunnel Syndrome Pain in the Emergency Department: A Case Report.

Puebla DL, Luchitsky I, Montes De Oca R, Shalaby M, Farrow RA 2nd. Puebla DL, et al. Among authors: montes de oca r. Clin Pract Cases Emerg Med. 2024 Feb;8(1):68-71. doi: 10.5811/cpcem.1265. Clin Pract Cases Emerg Med. 2024. PMID: 38546317 Free PMC article.

7

Implementation of an Ultrasound-Guided Regional Anesthesia Program in the Emergency Department of a Community Teaching Hospital.

Farrow RA 2nd, Shalaby M, Newberry MA, Montes De Oca R, Kinas D, Farcy DA, Zitek T. Farrow RA 2nd, et al. Among authors: montes de oca r. Ann Emerg Med. 2024 Jun;83(6):509-518. doi: 10.1016/j.annemergmed.2023.11.013. Epub 2023 Dec 22. Ann Emerg Med. 2024. PMID: 38142373

8

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.

Anderson KC, Auclair D, Adam SJ, Agarwal A, Anderson M, Avet-Loiseau H, Bustoros M, Chapman J, Connors DE, Dash A, Di Bacco A, Du L, Facon T, Flores-Montero J, Gay F, Ghobrial IM, Gormley NJ, Gupta I, Higley H, Hillengass J, Kanapuru B, Kazandjian D, Kelloff GJ, Kirsch IR, Kremer B, Landgren O, Lightbody E, Lomas OC, Lonial S, Mateos MV, Montes de Oca R, Mukundan L, Munshi NC, O'Donnell EK, Orfao A, Paiva B, Patel R, Pugh TJ, Ramasamy K, Ray J, Roshal M, Ross JA, Sigman CC, Thoren KL, Trudel S, Ulaner G, Valente N, Weiss BM, Zamagni E, Kumar SK. Anderson KC, et al. Among authors: montes de oca r. Clin Cancer Res. 2021 Oct 1;27(19):5195-5212. doi: 10.1158/1078-0432.CCR-21-1059. Clin Cancer Res. 2021. PMID: 34321279 Free PMC article.

9

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo.

Montes de Oca R, Alavi AS, Vitali N, Bhattacharya S, Blackwell C, Patel K, Seestaller-Wehr L, Kaczynski H, Shi H, Dobrzynski E, Obert L, Tsvetkov L, Cooper DC, Jackson H, Bojczuk P, Forveille S, Kepp O, Sauvat A, Kroemer G, Creighton-Gutteridge M, Yang J, Hopson C, Yanamandra N, Shelton C, Mayes P, Opalinska J, Barnette M, Srinivasan R, Smothers J, Hoos A. Montes de Oca R, et al. Mol Cancer Ther. 2021 Oct;20(10):1941-1955. doi: 10.1158/1535-7163.MCT-21-0035. Epub 2021 Jul 12. Mol Cancer Ther. 2021. PMID: 34253590 Free PMC article.

10

Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.

Nooka AK, Weisel K, van de Donk NW, Routledge D, Otero PR, Song K, Quach H, Callander N, Minnema MC, Trudel S, Jackson NA, Ahlers CM, Im E, Cheng S, Smith L, Hareth N, Ferron-Brady G, Brouch M, Montes de Oca R, Paul S, Holkova B, Gupta I, Kremer BE, Richardson P. Nooka AK, et al. Among authors: montes de oca r. Future Oncol. 2021 Jun;17(16):1987-2003. doi: 10.2217/fon-2020-1269. Epub 2021 Mar 8. Future Oncol. 2021. PMID: 33682447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters